Bayer traded at 54.03 this Tuesday August 16th, increasing 0.47 or 0.88 percent since the previous trading session. Looking back, over the last four weeks, Bayer gained 2.53 percent. Over the last 12 months, its price rose by 12.89 percent. Looking ahead, we forecast Bayer to be priced at 52.16 by the end of this quarter and at 46.63 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
54.03
Daily Change
0.88%
Yearly
12.89%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Covestro 32.66 0.38 1.18% -40.53%
Air Liquide 135.56 -1.80 -1.31% -9.24%
Arkema 90.44 -0.76 -0.83% -17.41%
Akzo Nobel 70.34 0.08 0.11% -32.59%
Alcon AG 65.58 0.24 0.37% 1.58%
Amarin 1.62 -0.06 -3.29% -71.21%
Artemis Alpha 315.53 0.03 0.01% -24.51%
AstraZeneca 10,904.00 -58.00 -0.53% 27.01%
BASF 44.38 0.32 0.73% -34.50%
Bayer 54.03 0.47 0.88% 12.89%
Beiersdorf 102.55 0.30 0.29% -2.93%
Corteva Inc 61.61 -0.15 -0.24% 36.40%
Vinci 94.87 0.39 0.41% 4.89%
DSM 144.60 -2.45 -1.67% -18.56%
Essilor 161.95 -3.20 -1.94% -1.20%
Fresenius Medical Care 37.24 0.54 1.47% -46.48%
Fresenius 24.92 0.28 1.14% -46.88%
Genmab 2,666.00 -26.00 -0.97% -9.99%
Givaudan 3,330.00 -105.00 -3.06% -28.00%
GRIFOLS 13.76 -0.03 -0.18% -32.44%
GlaxoSmithKline 1,423.40 17.40 1.24% -6.13%
Henkel 65.46 0.34 0.52% -21.21%
Hikma Pharmaceutical 1,538.50 -16.00 -1.03% -40.44%
Johnson Matthey 2,273.00 26.00 1.16% -23.00%
Linde 305.20 1.30 0.43% 14.91%
Lonza Group 560.40 -9.20 -1.62% -24.11%
Merck 183.25 -2.70 -1.45% -7.54%
Novartis 80.87 0.42 0.52% -6.77%
Nutrien Ltd 117.14 1.77 1.53% 52.82%
Philips 19.87 0.37 1.91% -47.43%
PPG Industries 136.79 0.40 0.29% -17.89%
Roche Holding 313.75 -4.15 -1.31% -15.20%
Sanofi 85.96 0.84 0.99% -3.73%
SAP 92.08 -1.21 -1.30% -27.55%
Solvay 86.60 -0.08 -0.09% -24.92%
UCB 72.82 -0.60 -0.82% -26.10%
Umicore 36.49 0.10 0.27% -37.54%

Indexes Price Day Year
EU50 3793 3.50 0.09% -9.61%
DE40 13854 37.02 0.27% -12.99%

Bayer
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non